Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System

BREA, Calif., Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1 implant system. Boa... Devices, Dental, FDA Nobel Biocare, Envista, N1 implant

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2047336

Source: HSMN NewsFeed - December 27, 2021 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing | Pharmaceuticals